Association of

COVID-19 Inflammatory parameters Outcome PADI2 PADI4 Polymorphisms

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Mar 2024
Historique:
received: 15 11 2023
revised: 27 02 2024
accepted: 10 03 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: epublish

Résumé

Enzymes of the peptidylarginine deiminase family (PADs) play a relevant role in the pathogenesis of COVID-19. However, the association of single nucleotide polymorphisms (SNPs) in their genes with COVID-19 severity and death is unknown. We included 1045 patients who were diagnosed with COVID-19 between October 2020 and December 2021. All subjects were genotyped for 291 patients presented had severe COVID-19 according to PaO Our results suggest that the haplotypic combination of GTACC and some individual genotypes of

Sections du résumé

Background UNASSIGNED
Enzymes of the peptidylarginine deiminase family (PADs) play a relevant role in the pathogenesis of COVID-19. However, the association of single nucleotide polymorphisms (SNPs) in their genes with COVID-19 severity and death is unknown.
Methodology UNASSIGNED
We included 1045 patients who were diagnosed with COVID-19 between October 2020 and December 2021. All subjects were genotyped for
Results UNASSIGNED
291 patients presented had severe COVID-19 according to PaO
Conclusions UNASSIGNED
Our results suggest that the haplotypic combination of GTACC and some individual genotypes of

Identifiants

pubmed: 38524554
doi: 10.1016/j.heliyon.2024.e27997
pii: S2405-8440(24)04028-3
pmc: PMC10958703
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27997

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ilse Adriana Gutiérrez-Pérez (IA)

Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, 39000, Mexico.

Ivette Buendía-Roldán (I)

Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, 14080, Mexico.

Oscar Zaragoza-García (O)

Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, 39000, Mexico.

Gloria Pérez-Rubio (G)

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, 14080, Mexico.

José Rafael Villafan-Bernal (JR)

Investigador por Mexico, Laboratory of Immunogenomics and Metabolic Disease, Mexican National Institute of Genomic Medicine (INMEGEN), Mexico City, 14610, Mexico.

Leslie Chávez-Galán (L)

Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, 14080, Mexico.

Isela Parra-Rojas (I)

Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, 39000, Mexico.

Rafael de Jesús Hernández-Zenteno (RJ)

COPD Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, 14080, Mexico.

Ingrid Fricke-Galindo (I)

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, 14080, Mexico.

Natividad Castro-Alarcón (N)

Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, 39000, Mexico.

Brandon Bautista-Becerril (B)

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, 14080, Mexico.

Ramcés Falfán-Valencia (R)

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, 14080, Mexico.

Iris Paola Guzmán-Guzmán (IP)

Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, 39000, Mexico.

Classifications MeSH